Investment Thesis
Bioquest Corp exhibits severe financial distress with negative stockholders' equity of -$536.4K, indicating the company is technically insolvent. Revenue generation is minimal at $31K while operating losses reach -$49.7K, demonstrating the company cannot sustain operations. Critically low liquidity (0.03x current ratio) combined with negative operating and free cash flows (-$29K) suggests imminent operational collapse.
Strengths
- Minimal long-term debt burden (N/A long-term debt)
Risks
- Negative stockholders' equity of -$536.4K indicating technical insolvency
- Severe liquidity crisis with current ratio of 0.03x and negative quick ratio
- Unsustainable operations with negative operating margin of -160.4% and net margin of -398.5%
- Cash burn rate exceeds revenue generation by 10x with operating cash flow of -$18.6K
- Minimal revenue base of only $31K suggests inability to support operations
- Deteriorating net income trending worse year-over-year (+64.7% loss increase)
- Zero insider transactions in past 90 days indicating potential abandonment
- Stale data from July 2022 raises concerns about current company status
Key Metrics to Watch
- Stockholders' equity recovery trajectory
- Cash position sustainability and burn rate
- Operating revenue growth and path to positive margins
- Total liabilities reduction progress
- Operating cash flow improvement and cash runway remaining
Financial Metrics
Revenue
31.0K
Net Income
-123.4K
EPS (Diluted)
$-0.06
Free Cash Flow
-29.0K
Total Assets
15.0K
Cash
15.0K
Profitability Ratios
Gross Margin
N/A
Operating Margin
-160.4%
Net Margin
-398.5%
ROE
N/A
ROA
-825.3%
FCF Margin
-93.5%
Balance Sheet & Liquidity
Current Ratio
0.03x
Quick Ratio
-0.49x
Debt/Equity
N/A
Debt/Assets
3,686.9%
Interest Coverage
-2.09x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-21T10:58:10.293279 |
Data as of: 2022-07-31 |
Powered by Claude AI